Arne Freundt took over as Puma CEO effective immediately to replace Bjorn Gulden who relinquished the post to head rival Adidas.
Puma’s appointment of Freundt as chief executive with immediate effect on Tuesday came several weeks before it was initially announced.
Freundt, according to Puma, is receiving a four-year contract effective from January 1 of 2023. Gulden’s mandate as a Puma SE Management Board member expires at the end of 2022.
Héloïse Temple-Boyer, Chair of the Supervisory Board of Puma, called Freundt the ideal choice to continue Puma’s very successful path and to further accelerate the company’s momentum.
Freundt has held various positions for Puma for over ten years and was responsible for framing corporate strategy, taking care of the Global Direct-to-Consumer business, and the Region EMEA as a General Manager.
He has also been a member of the Management Board as Chief Commercial Officer since June 2021.


Trump Signs Executive Order Targeting Big-Money College Athlete Payouts
Nikkei 225 Hits Record High Above 56,000 After Japan Election Boosts Market Confidence
Trump Set to Announce Washington D.C. as Host of 2027 NFL Draft
Bank of Japan Signals Readiness for Near-Term Rate Hike as Inflation Nears Target
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
What makes a good football coach? The reality behind the myths
India–U.S. Interim Trade Pact Cuts Auto Tariffs but Leaves Tesla Out
‘The geezer game’ – a nearly 50-year-old pickup basketball game – reveals its secrets to longevity
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Washington Post Publisher Will Lewis Steps Down After Layoffs
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Trump Signs Executive Order Threatening 25% Tariffs on Countries Trading With Iran
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Vietnam’s Trade Surplus With US Jumps as Exports Surge and China Imports Hit Record
Japanese Pharmaceutical Stocks Slide as TrumpRx.gov Launch Sparks Market Concerns 



